Supplementary File 4 from Distinct TP63 Isoform-Driven Transcriptional Signatures Predict Tumor Progression and Clinical Outcomes

crossref(2023)

引用 0|浏览0
暂无评分
摘要

Components of tumor progression TAp63 (4.1) and Î"Np63 (4.2) signatures used in this study. Pathways enriched in TAp63 (4.3) and Î"Np63 (4.4) tumor progression signatures.

更多
查看译文
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要